Skip to main content

Table 5 Baseline characteristics of participants relative to development of CKD during the 6-year follow-up period

From: The association between dyslipidemia and the incidence of chronic kidney disease in the general Zhejiang population: a retrospective study

 

CKD

(n = 227)

Without CKD

(n = 4956)

P value

Age (Years)

72(23)

47(22)

< 0.001

Male (%)

139(61.2)

3037(61.3)

0.989

BMI (kg/m2)

24.32 ± 2.78

23.18 ± 3.01

< 0.001

SBP (mmHg)

139.80 ± 20.81

124.91 ± 18.79

< 0.001

DBP (mmHg)

80.61 ± 12.02

75.31 ± 11.21

< 0.001

TG (mmol/L)

1.71 ± 1.29

1.42 ± 1.11

0.001

ΔTG

0.25 ± 0.28

0.11 ± 0.16

< 0.001

TC (mmol/L)

5.12 ± 1.02

4.83 ± 0.91

< 0.001

ΔTC (mmol/L)

0.27 ± 0.36

0.15 ± 0.23

< 0.001

HDL-C (mmol/L)

1.31 ± 0.28

1.30 ± 0.31

0.048

LDL (mmol/L)

2.98 ± 0.82

2.82 ± 0.77

< 0.001

ΔLDL (mmol/L)

0.15 ± 0.25

0.08 ± 0.19

< 0.001

BUN (mmol/L)

5.68 ± 1.17

4.96 ± 1.14

< 0.001

FPG (mmol/L)

5.46 ± 1.01

5.24 ± 0.82

< 0.001

SUA (mg/dl)

6.24 ± 1.41

5.59 ± 1.33

< 0.001

Hypertension (%)

103(45.4)

746(15.1)

< 0.001

Diabetes (%)

25(11.0)

173(3.5)

< 0.001

Baseline eGFR (ml/min/1.73m2)

68.71 ± 7.62

87.01 ± 15.12

< 0.001

Ending eGFR (ml/min/1.73m2)

48.75 ± 8.76

72.38 ± 10.99

< 0.001

  1. ΔTG, ΔTC and ΔLDL-C: ending TG/ TC/ LDL minus baseline TG/ TC/ LDL, respectively
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us